Cost-effective, flexible and high-yield system for manufacturing cannabinoids
While rare cannabinoids may hold tremendous potential as new treatments for diseases with high unmet medical needs, it is not economically feasible to extract and…
Read More...
Browsing Tag
cannabinoids
Revive Therapeutics: Focused on Infectious Diseases, Psychedelics & CBD
Patent and license portfolio focused on infectious diseases, psychedelics, and CBD
Revive Therapeutics is a life sciences…
BTV News Alert: InMed Advances a Rare Cannabinoid that Could Treat Skin &…
InMed is the first to advance a rare cannabinoid to human clinical trials
InMed Pharmaceuticals is a biopharmaceutical…
InMed Pharmaceuticals: Leading the Way in Rare Cannabinoids
Rare cannabinoids have potential to treat skin and eye diseases
InMed Pharmaceuticals is a leader in developing rare…
Bringing Cannabis to the Wellness Market
CEO, Penny White explains how the company is bringing cannabis into the international wellness market
The Yield Growth…
FSD: Advancing Research and Development
Advancing R&D to fulfill unmet medical needs.
FSD's R&D platform focuses on cannabinoids and their potential for…
A Patent Pending Technology to Enhance Cannabis Extraction
Single-step Extraction=Higher Yields, at Faster Rates
World-Class Extractions provides precision single step mobile…
First to Patent the Production of Cannabinoid Concentrate
CBD & THC Molecules Ready to Infuse Products in October 2019
What Nextleaf is as a molecule factory. They are the first…
New Cannabis Facility Means More Cultivation
" FSD Pharma would have three point nine million square feet of facility to produce 400 thousand kg of cannabis year over year.…
Chris Bunka, CEO of Lexaria Bioscience shares their DehydraTECH technology
“Lexaria Bioscience has the actual opportunity of changing the world. We can do it through saving lives, making health…
